BCD-264

· Biocad

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BCD-264, covering 2024-03-06 to 2024-03-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Efficacy and Safety of Monotherapy With BCD-264 and Darzalex in Subjects With Relapsed and Refractory Multiple Myeloma [Phase 3]

See pricing